Is CyberArk The Next Big Cybersecurity Stock?
CyberArk Software (NASDAQ: CYBR) recently reported phenomenal quarter numbers, passing…
Sell
47
KMB Quote, Financials, Valuation and Earnings
Last price:
$139.54
Seasonality move
:
3.6%
Day range:
$138.84 - $140.45
52-week range:
$123.02 - $150.45
Dividend yield:
3.52%
P/E ratio:
18.53x
P/S ratio:
2.35x
P/B ratio:
55.25x
Volume:
1.5M
Avg. volume:
2.1M
1-year change:
12.4%
Market cap:
$46.4B
Revenue:
$20.1B
EPS (TTM):
$7.55
Kimberly-Clark Number of Institutional Trades
Kimberly-Clark Volume of Institutional Trades
Amount of Institutions Buying
--
(Last Month)
Amount of Institutional Buying
$50.8B
(Last 6 Months)
Current Institutional Ownership Percentage
--
Amount of Institutions Selling
--
(Last Month)
Amount of Institutional Selling
$39.2B
(Last 6 Months)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Kimberly-Clark Institutional Ownership
-
What Percentage Of KMB Is Owned by Institutions?
-- of KMB is owned by institutions.
-
How Many Institutions Own KMB Shares?
Kimberly-Clark stock is owned by 2,770 institutional shareholders at this time.
-
Have Institutions Been Buying KMB Stock?
Yes, institutions have bought 214.5M shares of KMB in the last quarter.
-
Have Institutions Been Selling KMB Stock?
Yes, institutions have sold 154.5M shares of KMB over the last quarter.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is the Market Going to Go Lower?
The last month has been extremely difficult for the stock…
2 Dividend Stocks to Buy in a Recession
While many economists and investors initially expected 2025 to be…
Stock Ideas
Buy
53
Is AAPL Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 35x
Buy
54
Is NVDA Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 41x
Buy
51
Is MSFT Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 33x
Alerts
Buy
52
RGC alert for Mar 18
Regencell Bioscience Holdings [RGC] is up 73.51% over the past day.
Buy
63
EXOD alert for Mar 18
Exodus Movement [EXOD] is down 3.96% over the past day.
Sell
45
MNPR alert for Mar 18
Monopar Therapeutics [MNPR] is up 0.93% over the past day.
